The DEAD-box protein family of RNA helicases: sentinels for a myriad of cellular functions with emerging roles in tumorigenesis

被引:0
作者
Mohamed A. M. Ali
机构
[1] Ain Shams University,Department of Biochemistry, Faculty of Science
来源
International Journal of Clinical Oncology | 2021年 / 26卷
关键词
Carcinogenesis; Cellular processes; DEAD-box proteins; Oncogenes; RNA metabolism; Tumor suppressor genes;
D O I
暂无
中图分类号
学科分类号
摘要
DEAD-box RNA helicases comprise a family within helicase superfamily 2 and make up the largest group of RNA helicases. They are a profoundly conserved family of RNA-binding proteins, carrying a generic Asp–Glu–Ala–Asp (D–E–A–D) motif that gives the family its name. Members of the DEAD-box family of RNA helicases are engaged in all facets of RNA metabolism from biogenesis to decay. DEAD-box proteins ordinarily function as constituents of enormous multi-protein complexes and it is believed that interactions with other components in the complexes might be answerable for the various capacities ascribed to these proteins. Therefore, their exact function is probably impacted by their interacting partners and to be profoundly context dependent. This may give a clarification to the occasionally inconsistent reports proposing that DEAD-box proteins have both pro- and anti-proliferative functions in cancer. There is emerging evidence that DEAD-box family of RNA helicases play pivotal functions in various cellular processes and in numerous cases have been embroiled in cellular proliferation and/or neoplastic transformation. In various malignancy types, DEAD-box RNA helicases have been reported to possess pro-proliferation or even oncogenic roles as well as anti-proliferative or tumor suppressor functions. Clarifying the exact function of DEAD-box helicases in cancer is probably intricate, and relies upon the cellular milieu and interacting factors. This review aims to summarize the current data on the numerous capacities that have been ascribed to DEAD-box RNA helicases. It also highlights their diverse actions upon malignant transformation in the various tumor types.
引用
收藏
页码:795 / 825
页数:30
相关论文
共 576 条
  • [91] Shih JW(2002)The RNA-binding protein DDX1 promotes primary microRNA maturation and inhibits ovarian tumor progression Br J Cancer 86 1957-85
  • [92] Tsai TY(2000)Translation initiation factor eIF-4A1 mRNA is consistently overexpressed in human melanoma cells in vitro Anticancer Res 20 2489-892
  • [93] Chao CH(2015)Decreased proliferation of human melanoma cell lines caused by antisense RNA against translation factor eIF-4A1 Biochem Soc Trans 43 1227-1381
  • [94] Soto-Rifo R(2015)Enhanced expression of translation factor mRNAs in hepatocellular carcinoma Cell Death Dis 6 e1603-402
  • [95] Rubilar PS(2012)Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence Br J Cancer 106 1297-958
  • [96] Limousin T(2014)The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape Int J Gynecol Cancer 24 908-28326
  • [97] Fuller-Pace FV(2013)Impact of genomic stability on protein expression in endometrioid endometrial cancer Science 340 82-22699
  • [98] Fuller-Pace FV(2018)Decreased expression of EIF4A1 after preoperative brachytherapy predicts better tumor-specific survival in cervical cancer Oncol Rep 39 883-92
  • [99] Moore HC(2019)Translational repression and eIF4A2 activity are critical for microRNA-mediated gene regulation Future Med Chem 11 1357-3513
  • [100] Clark EL(2016)A double-edged function of DDX3, as an oncogene or tumor suppressor, in cancer progression (review) Am J Cancer Res 6 387-669